ResearcherUniversity of California, Los AngelesNo recent work listed
Irmina A. Elliott
Matched on ORCID iD 0000-0002-1138-9053; OpenAlex author ID A5078484448. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 1 paper
Papers 4
- NAD+ depletion by type I interferon signaling sensitizes pancreatic cancer cells to NAMPT inhibition. Co-author DOI 10.1073/pnas.2012469118↗
- Lysosome inhibition sensitizes pancreatic cancer to replication stress by aspartate depletion. Co-author DOI 10.1073/pnas.1812410116↗
- A Comprehensive Assessment of Accurate Lymph Node Staging and Preoperative Detection in Resected Pancreatic Cancer. Co-author DOI 10.1007/s11605-017-3607-7↗
- Histone deacetylase inhibitors provoke a tumor supportive phenotype in pancreatic cancer associated fibroblasts. First author DOI 10.18632/oncotarget.13572↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Timothy R. Donahue · 4 shared papers, 2017–2021 · strength 0.31
- Paper NAD+ depletion by type I interferon signaling sensitizes pancreatic cancer cells to NAMPT inhibition. DOI 10.1073/pnas.2012469118↗
- Paper A Comprehensive Assessment of Accurate Lymph Node Staging and Preoperative Detection in Resected Pancreatic Cancer. DOI 10.1007/s11605-017-3607-7↗
- Paper Lysosome inhibition sensitizes pancreatic cancer to replication stress by aspartate depletion. DOI 10.1073/pnas.1812410116↗
- Razmik Ghukasyan · 3 shared papers, 2017–2021 · strength 0.23
- Paper NAD+ depletion by type I interferon signaling sensitizes pancreatic cancer cells to NAMPT inhibition. DOI 10.1073/pnas.2012469118↗
- Paper Lysosome inhibition sensitizes pancreatic cancer to replication stress by aspartate depletion. DOI 10.1073/pnas.1812410116↗
- Paper Histone deacetylase inhibitors provoke a tumor supportive phenotype in pancreatic cancer associated fibroblasts. DOI 10.18632/oncotarget.13572↗
- Caius Gabriel Radu · 3 shared papers, 2017–2021 · strength 0.23
- Paper NAD+ depletion by type I interferon signaling sensitizes pancreatic cancer cells to NAMPT inhibition. DOI 10.1073/pnas.2012469118↗
- Paper Lysosome inhibition sensitizes pancreatic cancer to replication stress by aspartate depletion. DOI 10.1073/pnas.1812410116↗
- Paper Histone deacetylase inhibitors provoke a tumor supportive phenotype in pancreatic cancer associated fibroblasts. DOI 10.18632/oncotarget.13572↗
- Evan R. Abt · 2 shared papers, 2019–2021 · strength 0.17
- Alexandra M. Moore · 2 shared papers, 2019–2021 · strength 0.17
- David W. Dawson · 2 shared papers, 2017–2021 · strength 0.16
- Keke Liang · 1 shared paper, 2021 · strength 0.10
- Jing Cui · 1 shared paper, 2021 · strength 0.10
- Howard A. Reber · 1 shared paper, 2018 · strength 0.08
- Hideo Baba · 1 shared paper, 2018 · strength 0.08
- Mark D. Girgis MD · 1 shared paper, 2018 · strength 0.08
- V. Raman Muthusamy · 1 shared paper, 2018 · strength 0.08
- Toshiro Masuda · 1 shared paper, 2018 · strength 0.08
- Oscar Joe Hines · 1 shared paper, 2018 · strength 0.08
- Paul A. Toste · 1 shared paper, 2017 · strength 0.06
- Andrew Hieu Nguyen · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.